Back to RU Rubric Capital Management LP

TBPHTBPH

Showing 0 of 7 quarters

Position history for RURubric Capital Management LP's holdings in THERAVANCE BIOPHARMA INC

No. Rubric Capital Management exited its TBPH (Theravance Biopharma) position in Q4 2022. Its Q3 2022 13F listed 356,100 shares worth $3.6M. Rubric Capital Management held TBPH in 5 quarterly 13F filings before exiting.

Current Value

—

Current Shares

—

Total Value Change

$0

Total Shares Change

—

No position history available for this security.

Optional analytics helps us improve. How it’s used